THE DNA-DIAGNOSTICS FORM CONGENITAL ADRENAL HYPERPLASIA CHILDREN

THE DNA-DIAGNOSTICS FORM CONGENITAL ADRENAL HYPERPLASIA CHILDREN

In 2013 in territory Regional clinical hospital № 1 by him. prof. S. V. Ochapovskiy, Kuban interregional medico-genetic advice on program was examined 68 501 newborns. The method of research is to define 17aoksigidroprogesteron levei by immunofiuorescent analyses and CYP-21. The frequency of disease...

Full description

Bibliographic Details
Main Authors:	V. V. Grigoryan, V. A. Shashil, S. A. Matulevich
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2017-07-01
Series:	Кубанский научный медицинский вестник
Subjects:	congenital adrenal hyperplasia diagnoses newborn 21-hydroxylase cyp21
Online Access:	https://ksma.elpub.ru/jour/article/view/745

Similar Items

Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Jin-Ho Choi, et al.
Published: (2016-03-01)

Clinical Characteristics of Taiwanese Children With Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency in the Pre-screening Era
by: Cheng-Ting Lee, et al.
Published: (2010-02-01)

ANALYSIS CYP21A2 GENE MUTATIONS TECHNIQUE IN PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA
by: Chernushyn S. Yu., et al.
Published: (2014-02-01)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
by: Atsumi Tsuji-Hosokawa, et al.
Published: (2021-06-01)

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
by: Helmuth G. Dörr, et al.
Published: (2019-03-01)

IS CONGENITAL ADRENAL HYPERPLASIA DUE TO 21- HYDROXYLASE DEFICIENCY DECEPTIVE DISEASE? MANAGEMENT AND DIFFERENTIATION OF SYNDROME IN ADULTS
by: Anna Nowak
Published: (2017-12-01)

Clinical role of CYP2C19 polymorphisms in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Urh Grošelj, et al.
Published: (2016-02-01)

Congenital Adrenal Hyperplasia with Salt Wasting Crisis: A Case Report
by: Deependra Mandal, et al.
Published: (2020-01-01)

Newborn screening for congenital adrenal hyperplasia in New York State
by: Melissa Pearce, et al.
Published: (2016-06-01)

Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening
by: Shih-Yao Liu, et al.
Published: (2018-02-01)

Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care
by: Jin-Ho Choi, et al.
Published: (2017-02-01)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Myrthe J. M. Verhees, et al.
Published: (2021-03-01)

Rare and severe complications of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report
by: Ferreira Florbela, et al.
Published: (2013-02-01)

Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
by: Mouna Feki Mnif, et al.
Published: (2013-01-01)

Intron 2 Splice Mutation at CYP21 Gene in Patients with Congenital Adrenal Hyperplasia in the Republic of Macedonia
by: Anastasovska V, et al.
Published: (2010-01-01)

A Case of Bilateral Testicular Tumors Subsequently Diagnosed as Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Yan-Kun Sha, et al.
Published: (2016-01-01)

Study to assess the knowledge of caretakers regarding corticosteroid therapy in children with congenital adrenal hyperplasia – 21 hydroxylase deficiency
by: Vasantha Singarayan, et al.
Published: (2020-01-01)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020-08-01)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
by: Helmuth G. Dörr, et al.
Published: (2018-06-01)

A p.P30L Mutation at the CYP21A2 Gene in Macedonian Patients with Nonclassical Congenital Adrenal Hyperplasia
by: Anastasovska V, et al.
Published: (2010-01-01)

Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia
by: N. Torres, et al.
Published: (2003-10-01)

Fertility outcome in male and female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Mahdi Kamoun, et al.
Published: (2014-06-01)

Recurrent haematuria; a rare presentation of 46XX Congenital adrenal hyperplasia presenting late and reared as males – two cases
by: D. Karuppiah, et al.
Published: (2019-12-01)

CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica
by: Andrés Umaña-Calderón, et al.
Published: (2021-06-01)

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy
by: O.V. Rykova
Published: (2019-08-01)

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy
by: O.V. Rykova
Published: (2019-09-01)

Mass spectrometry: an essential tool to be used in discrimination between causes of congenital adrenal hyperplasia, and its benefits versus radioimmunoassay
by: Heba Asfour, et al.
Published: (2021-07-01)

Mutation detection of CYP21A2 gene in nonclassical congenital adrenal hyperplasia patients with premature pubarche
by: Mahsa Kolahdouz, et al.
Published: (2016-01-01)

Direct molecular diagnosis of CYP21A2 point mutations in Macedonian and Serbian patients with 21-hydroxylase deficiency
by: Anastasovska Violeta, et al.
Published: (2015-01-01)

Molecular genetic strategy for diagnosis of congenital adrenal hyperplasia in Serbia
by: Ugrin Milena, et al.
Published: (2017-01-01)

Two cases of male patients followed for a classical form of congenital adrenal hyperplasia (CAH), presenting an azoospermia: analysis and review of the literature
by: Clélia Fouques, et al.
Published: (2019-05-01)

sibs of Iraqi families affected by congenital adrenal hyperplasia
by: Rafia Al-Rawi, et al.
Published: (2006-07-01)

REPORT OF 285 PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA AND EVALUATION OF APPROXIMATE REVALENCE OF THE DISEASE IN IRAN
by: H. Moayeri, et al.
Published: (1999-06-01)

REPORT OF 285 PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA AND EVALUATION OF APPROXIMATE REVALENCE OF THE DISEASE IN IRAN
by: H. Moayeri, et al.
Published: (1999-07-01)

Congenital adrenal hyperplasia at the Lagos University Teaching Hospital: A 10-year review
by: Elizabeth Eberechi Oyenusi, et al.
Published: (2016-01-01)

Compound heterozygosity for a whole gene deletion and p.R124C mutation in causing nonclassic congenital adrenal hyperplasia
by: Hamza Nasir, et al.
Published: (2018-09-01)

Forma no clásica de hiperplasia adrenal congénita en la niñez y adolescencia Non-classic way of congenital adrenal hyperplasia in childhood and adolescence
by: Francisco Carvajal Martínez, et al.
Published: (2010-04-01)

The value of serum levels of dehydroepiandrosterone sulfate as a screening test for late-onset congenital adrenal hyperplasia
by: Marcos Yorghi Khoury, et al.
Published: (2006-06-01)

Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Mouna Feki Mnif, et al.
Published: (2012-01-01)

21-Hydroxylase deficiency in Brazil
by: T.A.S.S. Bachega, et al.
Published: (2000-10-01)

Cannot write session to /tmp/vufind_sessions/sess_gmripfjrcdf8osb2iu8cfq8ru5